Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

10 May 2022

Abstract excerpt

Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS) are representative neurodegenerative diseases (NDs) characterized by degeneration of selective neurons, as well as the lack of effective biomarkers and therapeutic treatments. In the last decade, microRNAs (miRNAs) have gained considerable interest in diagnostics and therapy of NDs, owing to their aberrant expression and...

Topics

Join the communities discussing this publication.

GDF15 and Related Biomarkers
MicroRNA in disease regulation
Nuclear Receptors and Signaling

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35629192
DOI: 10.3390/jpm12050770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesPMID 35629192Read ↗

Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.Semantic proximity Read ↗

MicroRNAs (miRNAs) as Biomarkers for Diagnosis, Prognosis, or as Therapeutics Molecules in Neurodegenerative DiseasesSemantic proximity Read ↗

The involvement of microRNAs in neurodegenerative diseasesSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

An Overview of MicroRNAs as Biomarkers of ALSSemantic proximity Read ↗

miRNAs as Therapeutic Tools in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNAs in the pathogenesis of neurodegenerative disorders: Potential as therapeutic targetsSemantic proximity Read ↗

Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative DisordersSemantic proximity Read ↗

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewSemantic proximity Read ↗

MicroRNAs: novel therapeutic targets in neurodegenerative diseases.Semantic proximity Read ↗

New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseasesSemantic proximity Read ↗

The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic PotentialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.